These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7620422)

  • 1. Implantation metastasis alongside an intraperitoneal chemotherapy catheter in ovarian carcinoma.
    Warnock NG; Riley M
    Abdom Imaging; 1995; 20(3):262-3. PubMed ID: 7620422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraperitoneal carboplatin in advanced ovarian carcinoma.
    Delaloye JF; Tran L; Leyvraz S; Bauer J; De Grandi P
    Gynakol Geburtshilfliche Rundsch; 1993; 33(1):25-30. PubMed ID: 8471881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal chemotherapy in peritoneal malignancy: impact of intensive system care on practicability.
    Knüsli C; Ruff P; Laffer U; Stoll HR; Obrist R; Weber W; Obrecht JP
    Acta Med Austriaca; 1989; 16(3-4):70-3. PubMed ID: 2692376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CT image of primary ovarian cancer seeding to the peritoneal cavity].
    Inoue S; Yokouchi J; Matsuda H; Ishida J; Akada S; Mugishima K; Kaklzaki M; Kawana K; Abe K
    Rinsho Hoshasen; 1989 Nov; 34(12):1479-82. PubMed ID: 2593294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of acute peritoneal dialysis catheters for intraperitoneal chemotherapy instead of the semipermanent/permanent Tenkhoff catheters.
    Morales M; Dorta J
    Support Care Cancer; 1994 Mar; 2(2):132-3. PubMed ID: 8156267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
    Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
    J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermic intraperitoneal chemotherapy for the treatment of ovarian cancer: A brief overview of recent results.
    Roviello F; Roviello G; Petrioli R; Marrelli D
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):297-305. PubMed ID: 25900072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
    Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal catheter site metastasis in a patient with advanced ovarian cancer.
    Ramirez I; Bansal N; Hoffman M
    Am J Hosp Palliat Care; 2012 May; 29(3):241-2. PubMed ID: 21606122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal carcinomatosis due to transitional cell carcinoma of the bladder: CT findings in two patients.
    Pevarski DJ; Mergo PJ; Ros PR
    AJR Am J Roentgenol; 1995 Apr; 164(4):929-30. PubMed ID: 7726050
    [No Abstract]   [Full Text] [Related]  

  • 11. Transitional cell carcinoma of the renal pelvis with ovarian metastasis.
    Hsiu JG; Kemp GM; Singer GA; Rawls WH; Siddiky MA
    Gynecol Oncol; 1991 May; 41(2):178-81. PubMed ID: 2050310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
    Del Carmen MG; Supko JG; Horick NK; Rauh-Hain JA; Clark RM; Campos SM; Krasner CN; Atkinson T; Birrer MJ
    Cancer; 2016 Nov; 122(21):3297-3306. PubMed ID: 27421044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of effectiveness of intraperitoneal chemotherapy by intraperitoneal scintigraphy in patients with advanced ovarian carcinoma.
    Sugimura K; Okizuka H; Kaji Y; Ishida T; Iwanari O; Kitao M
    Clin Nucl Med; 1994 Jul; 19(7):600-3. PubMed ID: 7924100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with implanted subcutaneous ports for intraperitoneal chemotherapy in ovarian cancer.
    Malmström H; Carstensen J; Simonsen E
    Gynecol Oncol; 1994 Jul; 54(1):27-34. PubMed ID: 8020835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of metastasis of ovarian clear cell carcinoma to the peritoneum of the abdominal wall by positron emission tomography with (fluorine-18)-2-deoxyglucose.
    Ishiko O; Honda K; Hirai K; Sumi T; Ogita S; Koyama K; Kawabe J; Ochi H
    Oncol Rep; 2001; 8(1):67-9. PubMed ID: 11115571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
    Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
    Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with surgery and intraperitoneal hyperthermic perfusion (IPHP) for far-advanced gastrointestinal cancer with peritoneal seeding.
    Fujimoto S; Shrestha RD; Kobayashi K; Koike S; Kokubun M; Kiuchi S; Takahashi M; Konno C; Okui K
    Acta Med Austriaca; 1989; 16(3-4):76-80. PubMed ID: 2609917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intraoperative (hyperthermic) intraperitoneal chemotherapy--considerations and aspects of safe intra- and postoperative treatment with cytostatic drugs].
    Jähne J; Piso P; Schmoll E; Haulitschek-Hauss R; Sterzenbach H; Paul H; Pichlmayr R
    Langenbecks Arch Chir; 1997; 382(1):8-14. PubMed ID: 9157234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer.
    Cascales Campos P; Gil J; Parrilla P
    Eur J Surg Oncol; 2014 Aug; 40(8):970-5. PubMed ID: 24035502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intraperitoneal hyperthermic perfusion chemotherapy in recurrent ovarian cancer].
    Wydra D; Emerich J
    Ginekol Pol; 2002 Nov; 73(11):1044-7. PubMed ID: 12722397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.